UK rituximab trial/B-cell Research Projects



Preliminary B-CELL Project

UCL

The preliminary B-cell study was designed to confirm and extend the earlier work of Dr Amolak Bansal on B-cells but using a different cohort of ME patients.

View Project


B-cell research - PhD Project

UCL

Recent studies have identified abnormalities in the blood of patients, which have strengthened the suspicion that the immune system contributes to ME/CFS. Changes in populations of white blood cells, called B cells, in ME/CFS have been reported by several research groups including those in the UK. In addition, treatment with anti-B cell therapy using Rituximab by Fluge and colleagues in Norway have shown benefit to ME patients. This PhD project will investigate whether certain B cell products (antibodies and soluble factors) are involved in ME/CFS.

View Project



Return to Projects Overview


Last Update September 2017

Latest Tweets

© Copyright Invest in ME Research. All Rights Reserved. Let's Let's Do Research Research